BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND KDSR, Q06136, 2531, ENSG00000119537, FVT1
11 results:

  • 1. Response comparison of PLC and SLC with magnetic resonance elastography after TACE.
    Haas Y; Dosch MP; Vogl TJ
    Sci Rep; 2022 May; 12(1):8317. PubMed ID: 35585124
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers.
    Alrawashdeh W; Kamarajah SK; Gujjuri RR; Cambridge WA; Shrikhande SV; Wei AC; Abu Hilal M; White SA; Pandanaboyana S
    HPB (Oxford); 2022 Jun; 24(6):789-796. PubMed ID: 35042673
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Malnutrition as a risk factor of adverse postoperative outcomes in patients undergoing hepatic resection: analysis of US hospitals.
    Lee DU; Wang E; Fan GH; Hastie DJ; Addonizio EA; Chou H; Karagozian R
    Br J Nutr; 2022 Aug; 128(4):675-683. PubMed ID: 34551838
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults.
    Im PK; Millwood IY; Kartsonaki C; Guo Y; Chen Y; Turnbull I; Yu C; Du H; Pei P; Lv J; Walters RG; Li L; Yang L; Chen Z;
    BMC Med; 2021 Sep; 19(1):216. PubMed ID: 34530818
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of endoscopic reintervention for self-expandable metallic stent obstruction after stent-in-stent placement for malignant hilar biliary obstruction.
    Okuno M; Mukai T; Iwashita T; Ichikawa H; Iwasa Y; Mita N; Yoshida K; Iwata K; Tomita E; Shimizu M
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):211-218. PubMed ID: 30950234
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
    Leslie T; Ritchie R; Illing R; Ter Haar G; Phillips R; Middleton M; Bch B; Wu F; Cranston D
    Br J Radiol; 2012 Oct; 85(1018):1363-70. PubMed ID: 22700259
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. RGD-modified endostatin peptide 30 derived from endostatin suppresses invasion and migration of HepG2 cells through the αvβ3 pathway.
    Li S; Wei J; Yuan L; Sun H; Liu Y; Zhang Y; Li J; Liu X
    Cancer Biother Radiopharm; 2011 Oct; 26(5):529-38. PubMed ID: 21834652
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pyogenic liver abscess: an audit of 10 years' experience.
    Pang TC; Fung T; Samra J; Hugh TJ; Smith RC
    World J Gastroenterol; 2011 Mar; 17(12):1622-30. PubMed ID: 21472130
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.
    Peluso MR; Dixon JL
    Lipids; 1997 Aug; 32(8):811-23. PubMed ID: 9270972
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Promoter region of the rat gene encoding ornithine aminotransferase: transcriptional activity, sequence, and DNase-I-hypersensitive sites.
    Shull JD; Pennington KL; Rader AE
    Gene; 1993 Mar; 125(2):169-75. PubMed ID: 8462871
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Increased mutagenicity of N-nitrosodiethanolamine in human lymphocyte cultures after activation by alcohol dehydrogenase.
    Henn I; Eisenbrand G; Zankl H
    J Cancer Res Clin Oncol; 1989; 115(5):445-8. PubMed ID: 2808483
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.